Li Shu Fen
Li Shu Fen — Chief Physician — Breast Oncology — Tianjin Medical University Cancer Hospital
Specialties
Specializes in adjuvant chemotherapy after breast cancer surgery and comprehensive treatment of advanced breast cancer, including chemotherapy, endocrine therapy, targeted drug therapy, and biological therapy.
Education
Graduated from the Medical Department of Tianjin Medical University in 1984
Professional Experience
Female, chief physician, has been engaged in clinical oncology chemotherapy and related research work for 28 years, with profound expertise and rich clinical experience in the diagnosis and treatment of various malignant tumors, such as breast cancer, malignant lymphoma, lung cancer, ovarian cancer, and gastrointestinal tumors. She is especially skilled in adjuvant chemotherapy after breast cancer surgery and comprehensive treatment for advanced breast cancer, including chemotherapy, endocrine therapy, targeted drug therapy, and biological therapy. She keeps pace with the world's forefront and, based on standardized tumor treatment, provides individualized treatment for certain refractory tumors. She has conducted in-depth research and has practical experience in using molecular targeted drugs for breast cancer, lung cancer, malignant lymphoma, and other cancers. She also has extensive experience in the three-step analgesic approach for advanced cancer pain.
Professional Roles
Member of the Chinese Medical Association, Member of the Chinese Society of Clinical Oncology (CSCO), Member of the Expert Group of Tianjin Labor Capacity Appraisal Committee, Member of the Medical Accident Technical Appraisal Expert Group of Tianjin Medical Association